GLP-1 medications like Wegovy and Zepbound are reshaping employer health plans. As more self-insured employers evaluate coverage, questions around cost, utilization, and long-term impact are rising.
This guide breaks down current GLP-1 coverage trends, what employers are doing in 2026, and how to estimate potential plan exposure. Use the calculator below to see the average costs when providing a GLP-1 and how much you can save by adding CookUnity GLP-1 meals to your plan.
Employer coverage of GLP-1 medications for obesity and weight management is expanding — but not universally.
Self-insured employers are balancing:
Many plan sponsors are implementing prior authorization, step therapy, or coverage limits to manage utilization.
The central question for most benefits leaders is:
If we cover GLP-1 medications, what will it cost our plan?


GLP-1 plan impact depends on several factors:
Even modest adoption can materially affect pharmacy spend. For example - 10% eligibility, 20% adoption of eligible, 6 months average therapy, $800 net cost per user per month - this can result in significant annual spend for a mid-sized self-insured employer. Use the calculator above to estimate your potential GLP-1 exposure.


"Providing CookUnity meals along side GLP-1 treatment was a game changer for results!"
Connect With Us
Benefits leaders evaluate GLP-1 impact through PMPM (Per Member Per Month) cost. PMPM measures how new pharmacy spend spreads across the entire covered population. Even if only a small percentage of members use GLP-1 therapy, total cost is distributed across the plan.
Understanding PMPM impact is critical for:
As GLP-1 coverage expands, employers are implementing guardrails such as:
However, cost control alone does not address long-term outcomes. Many employers are now evaluating complementary programs that support nutrition, adherence, and cardiometabolic health alongside GLP-1 coverage.

GLP-1 medications impact appetite and metabolic health, but sustainable results depend heavily on dietary behavior and adherence. Some employers are exploring integrated approaches that combine:
Providing structured nutrition alongside GLP-1 coverage may help support better long-term outcomes while managing utilization risk.
Connect With Us
Before expanding GLP-1 coverage, self-insured employers should evaluate:
GLP-1 coverage is not simply a pharmacy decision — it is a broader plan design and population health strategy.

GLP-1 medications are a significant investment. To maximize the ROI of your pharmacy spend, nutrition must be more than an afterthought. CookUnity provides the high-protein, nutrient-dense meals essential for preserving lean muscle mass and stabilizing metabolic health during GLP-1 therapy. By integrating meal support directly into your plan, you address the 'lifestyle' gap that often leads to therapy discontinuation and wasted spend.
Connect With Us
Insights into clinical cost drivers, stop-loss implications, and data-driven strategies for managing GLP-1 pharmacy spend.

Some self-insured employers are expanding coverage, often with utilization management criteria in place. Coverage decisions vary widely by industry and plan size.

Cost depends on eligibility, adoption, therapy duration, and net cost after rebates. Even modest adoption can materially impact annual pharmacy spend.

PMPM reflects the additional per-member cost added to the health plan. This metric helps employers understand how GLP-1 spend affects total trend.

Employers may implement prior authorization, clinical criteria, or complementary support programs to manage utilization and long-term outcomes.
Understand your exposure. Model your impact. Then explore strategies that support sustainable outcomes beyond medication alone.
Connect With Us